Shawn Rose

Company: Nkarta Therapeutics

Job title: Chief Medical Officer & Head, Research & Development

Bio:

Shawn Rose is Chief Medical Officer and Head of R&D at Nkarta Inc., with over a dozen programs advanced from discovery to clinic, including approvals like Sotyktu™, Stelara™, and Tremfya™. He has held senior roles at Vividion, Magenta Therapeutics, Annexon, Johnson & Johnson, and Bristol-Myers Squibb, leading development across autoimmune, oncology, and genetic diseases. A former NIH physician, Dr. Rose trained at Northwestern in internal medicine and rheumatology. He is also an advisor to biotech firms and a mentor committed to shaping future leaders in science and medicine

Seminars:

Optimizing Immune Cell Target Selection to Deliver Effective Autoimmune Therapies 11:00 am

Evaluate which immune cell targets have demonstrated the greatest therapeutic benefits to guide treatment decisions Understand patient tolerance to targeting alternative immune cells to optimize safety and efficacy Leverage insights from Nkarta Therapeutics’ NK cell-based Non-Hodgkins Lymphoma therapy to predict autoimmune successRead more

day: Conference Day One Teal Track P1